Cargando…
Exploring the Role of TRIP-Brs in Human Breast Cancer: An Investigation of Expression, Clinicopathological Significance, and Prognosis
TRIP-Brs, a group of transcription factors (TFs) that modulate several mechanisms in higher organisms. However, the novel paradigm to target TRIP-Brs in specific cancer remains to be deciphered. In particular, comprehensive analysis of TRIP-Brs in clinicopathological and patients’ prognosis, especia...
Autores principales: | Mongre, Raj Kumar, Mishra, Chandra Bhushan, Jung, Samil, Lee, Beom Suk, Quynh, Nguyen Thi Ngoc, Anh, Nguyen Hai, Myagmarjav, Davaajragal, Jo, Taeyeon, Lee, Myeong-Sok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554327/ https://www.ncbi.nlm.nih.gov/pubmed/33102693 http://dx.doi.org/10.1016/j.omto.2020.09.003 |
Ejemplares similares
-
Inhibitory Role of TRIP-Br1/XIAP in Necroptosis under Nutrient/Serum Starvation
por: Sandag, Zolzaya, et al.
Publicado: (2020) -
Inhibitory role of TRIP-Br1 oncoprotein in anticancer drug-mediated programmed cell death via mitophagy activation
por: Jung, Samil, et al.
Publicado: (2022) -
The regulation of insulin receptor/insulin-like growth factor 1 receptor ratio, an important factor for breast cancer prognosis, by TRIP-Br1
por: Nguyen, Thi Ngoc Quynh, et al.
Publicado: (2022) -
Prognostic and Clinicopathological Significance of SERTAD1 in Various Types of Cancer Risk: A Systematic Review and Retrospective Analysis
por: Mongre, Raj Kumar, et al.
Publicado: (2019) -
SERTAD1 Sensitizes Breast Cancer Cells to Doxorubicin and Promotes Lysosomal Protein Biosynthesis
por: Nguyen, Hai Anh, et al.
Publicado: (2022)